Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Larocca

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Blood|September 2, 2015
How I treat fragile myeloma patientsAlessandra Larocca, Antonio Palumbo
European Journal of Internal Medicine|December 12, 2018
Special problems in the management of elderly patients with multiple myelomaFrancesca Gay, Alessandra Larocca
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
Evolving paradigms in the treatment of newly diagnosed multiple myelomaAlessandra Larocca, Antonio Palumbo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized ApproachAlessandra Larocca, Antonio Palumbo
Current Opinion in Oncology|August 2, 2017
Elderly patients with multiple myeloma: towards a frailty approach?Sonja Zweegman, Monika Engelhardt, Alessandra Larocca, et al.
Cancers|October 29, 2020
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma PatientsFrancesca Bonello, Mario Boccadoro, Alessandra Larocca
Frontiers in Oncology|February 21, 2020
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple MyelomaStefania Oliva, Mattia D'Agostino, Mario Boccadoro, et al.
Expert Review of Anticancer Therapy|November 30, 2016
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myelomaMarco Salvini, Francesca Bonello, Mario Boccadoro, et al.
Expert Opinion on Investigational Drugs|April 28, 2017
Novel investigational drugs active as single agents in multiple myelomaMattia D'Agostino, Marco Salvini, Antonio Palumbo, et al.
Future Oncology (London, England)|November 8, 2012
Current treatment strategies with lenalidomide in multiple myeloma and future perspectivesAlessandra Larocca, Federica Cavallo, Roberto Mina, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Blood|September 2, 2015
How I treat fragile myeloma patientsAlessandra Larocca, Antonio Palumbo
European Journal of Internal Medicine|December 12, 2018
Special problems in the management of elderly patients with multiple myelomaFrancesca Gay, Alessandra Larocca
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
Evolving paradigms in the treatment of newly diagnosed multiple myelomaAlessandra Larocca, Antonio Palumbo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized ApproachAlessandra Larocca, Antonio Palumbo
Current Opinion in Oncology|August 2, 2017
Elderly patients with multiple myeloma: towards a frailty approach?Sonja Zweegman, Monika Engelhardt, Alessandra Larocca, et al.
Cancers|October 29, 2020
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma PatientsFrancesca Bonello, Mario Boccadoro, Alessandra Larocca
Frontiers in Oncology|February 21, 2020
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple MyelomaStefania Oliva, Mattia D'Agostino, Mario Boccadoro, et al.
Expert Review of Anticancer Therapy|November 30, 2016
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myelomaMarco Salvini, Francesca Bonello, Mario Boccadoro, et al.
Expert Opinion on Investigational Drugs|April 28, 2017
Novel investigational drugs active as single agents in multiple myelomaMattia D'Agostino, Marco Salvini, Antonio Palumbo, et al.
Future Oncology (London, England)|November 8, 2012
Current treatment strategies with lenalidomide in multiple myeloma and future perspectivesAlessandra Larocca, Federica Cavallo, Roberto Mina, et al.
Pageof 10